This inventor holds 3 USPTO granted patents. Top assignees: The University of Texas System, University of California. Active years: 2002-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Culver City, CA (US) (2002)
- El Paso, TX (US) (2024)
Company Filing History:


Years Active: 2002-2026
Title: The Innovative Contributions of Renato J Aguilera
Introduction
Renato J Aguilera is a notable inventor based in El Paso, TX (US). He has made significant contributions to the field of cancer research through his innovative patents. With a total of 3 patents, Aguilera's work focuses on developing compounds that exhibit anticancer activity.
Latest Patents
One of his latest patents is titled "Pyrazole derivatives with anticancer activity." In this work, the inventors utilized a differential nuclear staining (DNS) assay to discover compounds with cytotoxic activity against the CEM cell line, which is known to be highly sensitive to various anti-cancer compounds. The compounds were synthesized based on a pyrazole backbone structure, and several newly synthesized compounds were tested to identify those with the highest activity. Notably, the SSK-3 compound was identified as effective in inducing apoptosis via phosphatidylserine membrane exposure and activation of caspase 3 in the CEM lymphoma cell line.
Another significant patent is "Endonuclease compositions and methods of use." This patent discloses methods for modulating apoptosis and altering programmed cell death events using novel Endo-SR gene compositions and the polypeptides encoded thereby. Additionally, it includes methods for repairing DNA, modulating genetic recombination in a cell, and altering DNA rearrangement in a host cell. The patent also outlines methods for designing and isolating peptidomimetics and other inhibitors of Endo-SR, which are useful in treating leukemias, lymphomas, and other cancers.
Career Highlights
Aguilera has worked with prestigious institutions such as the University of California and The University of Texas System. His experience in these organizations has contributed to his expertise in cancer research and innovation.
Collaborations
Throughout his career, Aguilera has collaborated with notable colleagues, including Christopher J Lyon and Subhas S Karki. These collaborations have further enhanced his research and development efforts in the field of cancer treatment.
Conclusion
Renato J Aguilera's innovative work in developing anticancer compounds and methods showcases his dedication to advancing medical science. His contributions are significant in the ongoing fight against cancer, and his patents reflect a commitment to improving treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile